SCHEMBL1476458

SCHEMBL1476458

COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(OS(=O)(=O)O)c3o2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.66
ACHE P22303 1/20 0.64
PLK1 P53350 1/20 0.64
BACE1 P56817 1/20 0.64
ALDH1A1 P00352 4/20 0.58
MAPK1 P28482 2/20 0.58
PPARG P37231 1/20 0.58
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
CYP3A4 P08684 2/20 0.57
PKM P14618 2/20 0.57
ABCB1 P08183 1/20 0.57
ABCG2 Q9UNQ0 1/20 0.57
FLT3 P36888 2/20 0.56
MAOB P27338 2/20 0.56
CYP19A1 P11511 1/20 0.56
CDK8 P49336 2/20 0.54
CDK9 P50750 2/20 0.54
GABRP O00591 1/20 0.54
GABRD O14764 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6365437 0.89 ACHE (0.80) APPACHEPLK1BACE1ALDH1A1
SCHEMBL4506253 0.84 APP (0.69) APPACHEPLK1BACE1ALDH1A1
SCHEMBL29358951 0.83 APP (0.93) APPACHEPLK1BACE1ALDH1A1
SCHEMBL6359647 0.80 ACHE (0.81) APPACHEPLK1BACE1PPARG
SCHEMBL29100197 0.79 APP (0.93) APPACHEPLK1BACE1ALDH1A1
SCHEMBL30619516 0.79 APP (0.93) APPACHEPLK1BACE1ALDH1A1
Moslosooflavone SCHEMBL6070206 0.78 ACHE (1.00) APPACHEPLK1BACE1ALDH1A1
Moslosooflavone SCHEMBL29822243 0.78 ACHE (1.00) APPACHEPLK1BACE1ALDH1A1
SCHEMBL31238014 0.78 ALDH1A1 (0.73) APPACHEPLK1BACE1ALDH1A1
SCHEMBL987020 0.78 ALDH1A1 (0.73) APPACHEPLK1BACE1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1909919-B1 FLAVONOID IN THE FORM OF A SYNERGIST FOR ENHANCING A SELF-BROWNING SUBSTANCE EFFECT MERCK PATENT GMBH (DE) 2014-07-23 EP disclosed
EP-2004136-B1 Use of flavonoids MERCK PATENT GMBH (DE) 2014-04-30 EP disclosed
US-8613910-B2 Flavonoids as synergists for enhancing the action of self-tanning substances MERCK PATENT GMBH (DE) 2013-12-24 US disclosed
EP-1860158-B1 Particles comprising a substrate and an anion-binding layer MERCK PATENT GMBH (DE) 2013-12-04 EP disclosed
US-7914893-B2 Particles comprising an anion-binding layer containing anion-forming organic active compounds, and method of making and using thereof MERCK PATENT GMBH (DE) 2011-03-29 US disclosed
US-20090317342-A1 USE OF FLAVONOIDS MERCK PATENT GESELLSCHAFT (DE) 2009-12-24 US disclosed
US-7588783-B2 5-Hydroxy-7-methoxy-2-(4'-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid; plant extracts; use in cosmetic for protecting skin, a pharmaceutical drug, food, or food supplement MERCK PATENT GMBH (DE) 2009-09-15 US disclosed
US-7588783-B2 5-Hydroxy-7-methoxy-2-(4'-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid; plant extracts; use in cosmetic for protecting skin, a pharmaceutical drug, food, or food supplement MERCK PATENT GMBH (DE) 2009-09-15 US disclosed
US-20080279793-A1 Flavonoids as Synergists for Enhancing the Action of Self-Tanning Substances MERCK PATENT GMBH (DE) 2008-11-13 US disclosed
EP-1689734-B1 FLAVONOID DERIVATIVE MERCK PATENT GMBH (DE) 2008-07-23 EP disclosed
US-20070275244-A1 Particles MERCK PATENT GMBH 2007-11-29 US disclosed
EP-1860158-A2 Particles comprising a substrate and an anion-binding layer MERCK PATENT GmbH (DE) 2007-11-28 EP disclosed
US-20070134172-A1 5-Hydroxy-7-methoxy-2-(4'-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid; plant extracts; use in cosmetic for protecting skin, a pharmaceutical drug, food, or food supplement EUROPEAN BRAND PARTICIPATIONS SA (LU) 2007-06-14 US disclosed
US-20070134172-A1 5-Hydroxy-7-methoxy-2-(4'-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid; plant extracts; use in cosmetic for protecting skin, a pharmaceutical drug, food, or food supplement EUROPEAN BRAND PARTICIPATIONS SA (LU) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070134172-A1 5-Hydroxy-7-methoxy-2-(4'-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid; plant extracts; use in cosmetic for protecting skin, a pharmaceutical drug, food, or food supplement CYP8B1, TYR, CUTA APP 4563/4885ACHE 1569/4885PLK1 2760/4885
US-20090317342-A1 USE OF FLAVONOIDS OR51E2, TAS2R20, TAS2R60 APP 1948/4885ACHE 123/4885PLK1 4295/4885
US-20080279793-A1 Flavonoids as Synergists for Enhancing the Action of Self-Tanning Substances TEAD3, TPI1, TEAD2 APP 2801/4885ACHE 122/4885PLK1 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.